partially solid nodules. The lesions were well detected in 100% cases. They were resected by wedge resection in all the cases. The final pathologic diagnosis confirmed 12 lung adenocarcinoma (6 lepidic growth adenocarcinoma, 3 adenocarcinoma in situ, 2 solid adenocarcinomas, 1 minimally invasive adenocarcinoma), 12 lung metastasis, 2 atypical adenomatous hyperplasia, 2 inflammatory nodules, 1 squamous carcinoma and 1 hamartoma. Clean margins were obtained in 28 patients (93,3%). There were not intraoperative and postoperative complications secondary to the procedure. Conclusion: The radioguided localization is a simple, easy and safe procedure for the diagnosis and treatment of small lung nodules. There were not problems of radiotracer lung diffusion and misplacement.
Background: Radical surgical resection of lung cancer with or without adjuvant treatment is still a prerequisite for cure. Advances in operative and postoperative care led to a decline in complications and mortality rates during the last decades. In spite of different additional modes of treatment, survival is still poor. Methods: We analyzed 968 patients who underwent lung resection for bronchial carcinoma, with non-small cell lung cancer during a 12-year period (January 2004-December 2017). Postoperative events studied were divided into major and minor complications or death during the first 30 days after surgery. Results: Of 968 patient, 690 (70.5%) were male and 278 (28.7%) female. Mean age 65.5 ± 9.4 years (range: 15-87 years). Lobectomy was the most used surgical modality in 566 (58.5%) patients, meanwhile pneumonectomy was performed in 112 (11.6%) of patients. Minor complications during surgery occurred in 45 (11.7%) of patients. Continuous air leakage was the most complication after surgery in 25.3%, followed by lung atelectasis in 21.3% and cardiovascular complications in 17%. Of the life threatening complications respiratory failure was the most events in 20.0% of patients, followed by broncho-pleural fistula in 18.7% and pulmonary edema in 15% of patients. The 30-day mortality rate was 3.8% (37) patients, 1.2% after single lobectomy and 13.4 % after pneumonectomy. Conclusion: Our results show low mortality and morbidity after lung cancer surgery. However, patients with reduced lung capacity, older age and those undergoing pneumonectomy should be treated with great care.
Coronavirus caused an epidemic in China in December 2019 at an animal market where live and dead animals were sold in Wuhan, China. In a short time, this epidemic spread to different continents. This virus has been called the 2019 new coronavirus (2019-nCoV) by the World Health Organization. Unlike both MERS-CoV and SARS-CoV, Covid-19 is the seventh member of the coronavirus family that infects humans. It is characteristic for Covid-19 pneumonia that there are subpleural localized ground glass opacities and numerous irregular areas of consolidation in both lungs and especially in the lower lobes.In this case study, we aimed to present a Covid-19 positive in 58 years old man patient with cough, high fever, beginning breathlessness and chest pain on the left, accompanied by pneumothorax in the left hemithorax, after covid -19 diagnosis. Radiographic imaging of the patient revealed pneumothorax on the left and ground-glass opacities in the bilateral lower lobes. The patient underwent tube thoracostomy from the left hemithorax lateral. It should be kept in mind that in patients with Covid-19 pneumonia, it may develop in pneumotoacies secondary to lung parenchymal damage. Mortality rates can be reduced in patients with early diagnosis and treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.